Results 81 to 90 of about 61,595 (255)
Acta Clinica Croatica, 2018 We report a unique case of undetectable serum levels of anti-müllerian hormone (AMH) in women with polycystic ovary syndrome (PCOS) who developed ovarian hyperstimulation syndrome (OHSS) during in vitro fertilization (IVF).
Ivan Grbavac +5 more
doaj +1 more source
Gender, Work &Organization, EarlyView.ABSTRACT Infertility is a working age population issue, meaning that many individuals undergoing fertility treatment are also in paid work—having to navigate conflicts between two often “greedy institutions,” which can both bring precarity. Traditional approaches to examining the work–life interface, focusing mainly on temporal issues, fail to account ...
Krystal Wilkinson +2 more
wiley +1 more source
The management of infertility associated with polycystic ovary syndrome [PDF]
, 2003 Polycystic ovary syndrome [PCOS] is the commonest cause of anovulatory infertility. Treatment modes available are numerous mainly relying on ovarian stimulation with FSH, a reduction in insulin concentrations and a decrease in LH levels as the basis of ...
Roy Homburg
core +1 more source
SPONTANEOUS OVARIAN HYPERSTIMULATION SYNDROME
Мать и дитя в Кузбассе, 2023 Ovarian Hyperstimulation syndrome (OHSS) is a rare disease that can lead to fatal complications, almost always associated with the induction of ovulation by gonadotropins or sometimes clomiphene citrate.
Лариса Егоровна Фетищева +6 more
doaj
Pharmacogenetics of follicle‐stimulating hormone action in the male
Andrology, Volume 14, Issue 4, Page 1064-1072, May 2026.Abstract Male factor infertility (MFI) is involved in half of the cases of couple infertility. The follicle‐stimulating hormone (FSH) therapy is considered efficient to improve semen parameters and pregnancy rate in patients with idiopathic MFI, following the lesson learned from hypogonadotropic hypogonadism.
Andrea Graziani +7 more
wiley +1 more source
Ovarian Hyperstimulation Syndrome in a Spontaneous Pregnancy [PDF]
, 2011 Introdução: O Síndrome de Hiperestimulação do Ovário (SHO) geralmente é descrito como uma complicação iatrogénica dos tratamentos de indução da ovulação.
Ferreira, A +5 more
core
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization [PDF]
, 2002 In a randomized multicenter study, the efficacies of two different GnRH agonists were compared with that of hCG for triggering final stages of oocyte maturation after ovarian hyperstimulation for in vitro fertilization.
Fauser, B.C.J.M. (Bart) +6 more
core +3 more sources
Health Science Reports, Volume 9, Issue 4, April 2026.ABSTRACT Background Infertility affects 8%–12% of couples worldwide; advanced maternal age combined with diminished ovarian reserve (DOR) significantly lowers IVF success. The flexible GnRH‐antagonist and progestin‐primed ovarian stimulation (PPOS), are increasingly adopted for freeze‐all strategies in this poor‐prognosis population; however, their ...
Jinghua Zhang +8 more
wiley +1 more source
Dopamine treatment for severe ovarian hyperstimulation syndrome [PDF]
, 2017 Seven oliguric patients with severe ovarian hyperstimulation syndrome following gonadotrophin treatment for in-vitro fertilization or gamete intra-Fallopian transfer, were treated with low doses of dopamine by peripheral infusion.
Diotallevi, L. +4 more
core
Unexplained Infertility: An Update
The Obstetrician &Gynaecologist, Volume 28, Issue 2, Page 100-108, April 2026.ABSTRACT Key Content Unexplained infertility accounts for up to 30% of cases of infertility. Potential causes for unexplained infertility have been proposed including reduced oocyte quality, poor endometrial receptivity, ovulatory PCOS, subclinical endometriosis and low semen quality.
Claudia Raperport +3 more
wiley +1 more source